Gene therapy represents a revolutionary medical frontier, yet recent incidents highlight critical ethical challenges in its implementation. A notable case emerging from China demonstrates how rapid advancement without robust regulatory frameworks and informed consent protocols can lead to serious consequences. This article examines the intersection of scientific innovation and ethical responsibility, exploring the importance of establishing rigorous safety standards, transparent clinical practices, and international guidelines to protect patients while enabling therapeutic progress in genetic medicine.

Summary auto-generated by AI from the original publisher's content. Editorial standards.